PT Transindo Antariksa Borneo

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNSFDIETSP2 refused lines

  Dietary ingredient without safety assurance

  The product appeared to be a dietary supplement or dietary ingredient for which there is inadequate information to provide reasonable assurance that it does not present a significant or unreasonable risk of illness or injury.

Questions about PT Transindo Antariksa Borneo

Is PT Transindo Antariksa Borneo on an FDA import alert?

Yes. As of October 26, 2026, PT Transindo Antariksa Borneo is on the red list of FDA Import Alert 54-15, “Supplements and ingredients containing kratom”, for mitragyna speciosa (kratom tea); FDA published the listing on July 27, 2023.

Has FDA refused shipments from PT Transindo Antariksa Borneo?

Yes. FDA refused 2 shipment lines from PT Transindo Antariksa Borneo between July 5, 2023 and January 4, 2024. The most recent, on January 4, 2024, was kratom (herbal and botanical teas ii, continued), charged as UNSFDIETSP (dietary ingredient without safety assurance).

Why did FDA refuse PT Transindo Antariksa Borneo's shipments?

The most frequent charge is UNSFDIETSP (dietary ingredient without safety assurance, 2 lines).

What is PT Transindo Antariksa Borneo's FEI number?

PT Transindo Antariksa Borneo's FDA Establishment Identifier (FEI) is 3027231834.

Can shipments from PT Transindo Antariksa Borneo still enter the U.S.?

Shipments of mitragyna speciosa (kratom tea) from PT Transindo Antariksa Borneo can be detained without physical examination under Import Alert 54-15; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).